7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiovascular Complications in Other Diseases
The heart is frequently affected by conditions that originate elsewhere in the body, leading to cardiovascular complications in other diseases. For instance, cancer treatments like chemotherapy can damage cardiac tissues, while chronic inflammatory diseases, such as rheumatoid arthritis, elevate the risk of heart attacks. These complications not only worsen a patient’s prognosis but also complicate treatment strategies. Managing cardiovascular risks in patients with systemic diseases demands a collaborative approach between cardiologists and other healthcare providers. From advanced diagnostic tools to innovative therapies, addressing cardiovascular complications in such cases ensures holistic care that reduces mortality and enhances overall well-being.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : Finite-Element and Electromagnetic Cardio-Vascular Simulation for Drug Testing, Monitoring, and Safety Projection Using Bansal B–Bio Framework
Abhishek Bansal, New Era Consultancy Services, India
Title : Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women with Breast Cancer Receiving Hormonal Therapy
Sofra Maria, Aretaieion University Hospital, Greece